Clinical trial

Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea

NCT00452855 · Central Jutland Regional Hospital, Other · Completed

Key facts

NCT number NCT00452855
Title Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea
Official title Postoperative Nausea and Vomiting Are Similar When Propofol or Sevoflurane Are Used as Adjuvant to Remifentanil During Anaesthesia for Gynaecological Surgery
Lead sponsor Central Jutland Regional Hospital, Other
Collaborators Nielsen, Jens OD, M.D.
Status Completed
Study type Interventional
Conditions Nausea, Vomiting
Intervention type Procedure
Interventions Sevoflurane-remifentanil anaesthesia
Enrollment 160
Start date Jan 1, 2002
Completion May 1, 2005
First posted Mar 28, 2007
Last update posted Mar 29, 2007
Countries Denmark

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies